ASAP announces new teams joining the Collaborative Research Network! Learn More
Aligning Science Across Parkinson's Logo Text
Submit site search
  • TMT proteomic data from mouse cortical neurons

    By on

    TMT proteomic data from mouse cortical neurons

  • Code for extraction of any user-defined information from uniprot

    By on

    Code for extraction of any user-defined information from Uniprot.

  • Sample vitrification and cryo-EM data acquisition

    By on

    Protocol describing sample vitrification and cryo-EM data acquisition.

  • His-ATG3-Y209A

    By on

    Plasmid for ATG3 mutant Y209A overexpression in E.Coli.

  • Coating coverslips for cell culture

    By on

    Coated coverslips provide a nourishing adherent surface for cell culture. This protocol provides step by step instruction on how to coat coverslips for cell culture.

  • powerEQTL: An R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis

    By on

    Genome-wide association studies (GWAS) have revealed thousands of genetic loci for common diseases. One of the main challenges in the post-GWAS era is to understand the causality of the genetic variants. Expression quantitative trait locus (eQTL) analysis has been proven to be an effective way to address this question by examining the relationship between gene expression and genetic variation in a sufficiently powered cohort. However, it is often tricky to determine the sample size at which a variant with a specific allele frequency will be detected to associate with gene expression with sufficient power. This is particularly demanding with single-cell RNAseq studies. Therefore, a user-friendly tool to perform power analysis for eQTL at both bulk tissue and single-cell level will be critical. Here, we presented an R package called powerEQTL with flexible functions to calculate power, minimal sample size, or detectable minor allele frequency in both bulk tissue and single-cell eQTL analysis. A user-friendly, program-free web application is also provided, allowing customers to calculate and visualize the parameters interactively.

  • twichma/Sequence-and-pattern-detection: Sequence and pattern detection code

    By on

    The code provided is for analyzing sequences and patterns.

  • Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

    By on

    Recent findings identified PD-associated autoimmune features. Using RNA sequencing, the authors found a broad gene expression profile in memory T cells and a specific PD-associated gene signature.

  • Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease

    By on

    Variants in the GBA1 and LRRK2 genes are the most common genetic risk factors associated with Parkinson disease (PD). Both genes are associated with lysosomal and autophagic pathways, with the GBA1 gene encoding for the lysosomal enzyme, glucocerebrosidase (GCase) and the LRRK2 gene encoding for the leucine-rich repeat kinase 2 enzyme. GBA1-associated PD is characterized by earlier age at onset and more severe non-motor symptoms compared to sporadic PD. Mutations in the GBA1 gene can be stratified into severe, mild and risk variants depending on the clinical presentation of disease. Both a loss- and gain- of function hypothesis has been proposed for GBA1 variants and the functional consequences associated with each variant is often linked to mutation severity. On the other hand, LRRK2-associated PD is similar to sporadic PD, but with a more benign disease course. Mutations in the LRRK2 gene occur in several structural domains and affect phosphorylation of GTPases. Biochemical studies suggest a possible convergence of GBA1 and LRRK2 pathways, with double mutant carriers showing a milder phenotype compared to GBA1-associated PD. This review compares GBA1 and LRRK2-associated PD, and highlights possible genotype-phenotype associations for GBA1 and LRRK2 separately, based on biochemical consequences of single variants.

  • Free-floating Mouse Brain Immunohistochemistry

    By on

    This protocol enables immunohistochemical staining of murine tissue with superior penetration of the tissue by the reagents due to the free-floating approach.

  • Expansion of mouse embryonic fibroblasts (MEFs) for hPSC cultures

    By on

    This protocol describes the expansion of mouse embryonic fibroblasts (MEFs) as feeder cells for human pluripotent stem cell (hPSC) culture.

  • AAVS1-SA-neo-CAGGS-PE2-2A-GFP

    By on

    It can be used to generate knock-in cell line faciliating prime editing. 

  • Subcellular proteomics of dopamine neurons in the mouse brain

    By on

    Understanding the proteome of dopamine neuron is difficult due to the complex cytoarchitecture of the neurons. The authors were able to map the somatodendritic and axonal proteomes of midbrain dopaminergic neurons.

  • Cell culture, transfection, immunocytochemistry, and imaging

    By on

    This protocol is to help with the maintenance, transfection, immunocytochemistry, and imaging of adherent mammalian cells

  • Macros and pipelines for analysis of image analysis

    By on

    ImageJ macros and pipelines for analysis of pUb puncta, Keima Ratio, p62nuclei and Parkin recruitment to mitochondria.

  • Basal ganglia neurons in healthy and parkinsonian primates generate recurring sequences of spikes

    By on

    Basal ganglia neurons fire in recognizable, repeating sequences of interspike intervals (ISIs), the incidence of which is influenced by the induction of Parkinsonism.

  • Rodent models based on endolysosomal genes involved in PArkinson’s disease

    By on

    Genes linked to endolysosomal function are connected to Parkinson's disease, suggesting a role in its development. Rodent models targeting these genes like LRRK2 and GBA1 show parkinsonian features, aiding in understanding and treating the disease.

  • Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

    By on

    Decreasing alpha-synuclein levels is a potential therapeutic approach for synucleinopathies. The authors identified CDK14 regulates alpha-synuclein and show reduction of CDK14 reduces alpha-synuclein and PD-like characteristics.

  • PGK EGFP-PPM1H-WT

    By on

    Plasmid: Mammalian expression of wild-type PPM1H.

  • Cylinder behavior test

    By on

    This protocol describes the cylinder behavior test.

Load More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.